Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128498) titled 'An Observational Study of Recombinant Human Thrombopoietin (rhTPO) in the Treatment of Infection-Associated Thrombocytopenia' on July 21.
Study Type: Observational study
Study Design:
Historical control
Primary Sponsor: Shandong Provincial Third Hospital
Condition:
Infection-associated thrombocytopenia
Intervention:
recombinant human thrombopoietin (rhTPO):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-30
Target Sample Size: recombinant human thrombopoietin (rhTPO):95;historical control group(Conventional treatment):95;
Countries of Recruitment:
China
To know ...